Form 4: Monster Beverage CCO Sells 30,000 Shares Under 10b5-1 Plan

Monster Beverage Corp's Chief Commercial Officer, Emelie Tirre, reported the sale of 30,000 common shares for approximately $2.2 million, executed under a pre-arranged 10b5-1 plan.

Summary

• Emelie Tirre, Chief Commercial Officer of Monster Beverage Corp (MNST), reported the sale of 30,000 shares of common stock.
• The transaction occurred on December 12, 2025, at a weighted average price of $73.31 per share, totaling approximately $2,199,300.
• Following the sale, Tirre beneficially owns 63,939 shares of common stock.
• The reported beneficial ownership includes 1,232 additional shares that were inadvertently omitted from a previous Form 4 filing due to an administrative error.
• The sale was executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction.
• The filing also details various employee stock options and Restricted Stock Units (RSUs) held by Tirre, with different vesting schedules and exercise prices, but no transactions were reported for these derivatives in this filing.

Sentiment

Score: 5

Explanation: A neutral score is assigned as this is a routine insider transaction under a 10b5-1 plan. While an insider sale can sometimes be viewed negatively, the pre-planned nature mitigates concerns about it being based on new, adverse information. The correction of a previous administrative error is a minor positive for transparency.

Positives

• The sale was conducted under a Rule 10b5-1 plan, suggesting it was pre-scheduled and not based on immediate, non-public information, which can mitigate concerns about insider selling.
• The disclosure corrected an administrative error from a previous filing, adding 1,232 shares to the reported beneficial ownership, which enhances transparency and accuracy.

Negatives

• An insider sale, even if pre-planned, reduces management's direct equity stake in the company, which some investors might perceive negatively.

Risks

• Potential for misinterpretation by investors regarding the insider sale, despite it being a 10b5-1 plan, which could lead to short-term negative sentiment.
• Risk of administrative errors in future filings if internal reporting processes are not consistently robust, potentially impacting reporting accuracy.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide information directly related to broader industry trends or competitive landscape within the beverage sector. Insider sales, especially those under 10b5-1 plans, are common and typically reflect personal financial planning rather than a change in company outlook.

Corporate Governance

Stakeholder Impact

• Shareholders: May observe a slight reduction in direct insider ownership, but the 10b5-1 plan mitigates concerns about the timing of the sale. The correction of a previous error improves transparency.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Continued vesting of employee stock options and Restricted Stock Units on various dates through March 14, 2029.

Key Dates

Recommendation

The filing details a routine insider sale by the Chief Commercial Officer under a pre-arranged 10b5-1 plan. Such transactions are typically for personal financial management and do not usually signal a change in the company's fundamental outlook. The correction of a minor administrative error in a previous filing is a positive for transparency. Without additional company-specific news or broader market context, this filing alone does not warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Monster Beverage, MNST, Insider Sale, Form 4, Emelie Tirre, Chief Commercial Officer, Stock Transaction, 10b5-1 Plan, Equity Sales